AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
23:02
The Capital Police detained a 34-year-old man found with a knife at the protest in Victory Square
22:59
The Trump administration intends to sell Israel a $2.8 billion package of munitions
22:49
Ministry of Labor: The WorkinRomania platform is blocked after the court suspended the list of occupations in shortage
22:37
German Chancellor Friedrich Merz rules out a minority government and is betting on a coalition of conservatives and Social Democrats
22:36
Foreign Ministry warns of strikes in Charleroi / Flights may be disrupted between September 16 and October 10
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
IT&C knowledge
OpenAI abandons plans to go public in 2026 / Sam Altman: “It would be an inappropriate time”
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
